Track the あすか製薬ホールディングス株式会社 stock price and the full management transaction log of the company, a publicly traded company based in Japan. Shares trade on the JP market, under the supervision of EDINET (Japan FSA). Operating in the Banks sector, あすか製薬ホールディングス株式会社 has logged 15 public disclosures. Market capitalisation: €40,044.2bn. The latest transaction was reported on 8 April 2026 (Holding update). Among the most active insiders: NIPPON ACTIVE VALUE FUND PLC. Every trade is accessible without an account.
15
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate あすか製薬ホールディングス株式会社 Buy (bullish), based on 11 analysts. Average price target: JP¥3,619.
21Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 11,333 of 29,063 companies
57.1
score / 100
Value
37
Quality
77
FCF yld-59%
Earn yld6.1%
EV/EBITDA·
ROE9.5%
Gross mgn·
Net mgn32%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Asuka Pharmaceutical Holdings Co., Ltd. es una empresa japonesa especializada en el sector farmacéutico, que ofrece productos y servicios relacionados con la salud. Cotiza en la Bolsa de Tokio bajo el símbolo XTKS.